CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ADBiotech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ADBiotech Co Ltd
39, Geodudanji 1-gil, Dongnae-myeon
Phone: +82 332614907p:+82 332614907 CHUNCHEON, 24398  South Korea Ticker: 179530179530
Business Summary
ADBiotech Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of veterinary drugs. The Company operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2048 Prepared feeds and feed ingredients for animals and fowls, except dog and cat

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Jang HyeokHan 64 8/1/2020 8/1/2020
Chief Executive Officer, Director Hong GeolJung 61
Internal Auditor Seung JunLee 41 3/30/2022 3/30/2022
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 57 (As of 12/31/2019)
Outstanding Shares: 9,140,444 (As of 9/30/2024)
Shareholders: 6,815
Stock Exchange: KDQ
Fax Number: +82 332614920


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024